Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade

Punita Ponda; Tara Carr; Matthew A. Rank; Jean Bousquet

doi:10.1016/j.jaip.2022.09.010

Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade

Punita Ponda, Tara Carr, Matthew A. Rank, Jean Bousquet

Allergy, Asthma and Clinical Immunology

Research output: Contribution to journal › Article › peer-review

Abstract

Chronic rhinitis encompassing both allergic and nonallergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated comorbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and nonallergic rhinitis, addressing the individual triggers of the disease as well as the patient-specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management, and treatment of nonallergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways, and digital health.

Original language	English (US)
Pages (from-to)	35-42
Number of pages	8
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	1
DOIs	https://doi.org/10.1016/j.jaip.2022.09.010
State	Published - Jan 2023

Keywords

Allergen immunotherapy
Allergic rhinitis
Care pathway
Digital health
Immunotherapy
Mobile Airways Sentinel NetworK
Nonallergic rhinitis

ASJC Scopus subject areas

Immunology and Allergy

Access to Document

10.1016/j.jaip.2022.09.010

Cite this

@article{f7022f9a36ea4976a77faab583bb3b85,

title = "Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade",

abstract = "Chronic rhinitis encompassing both allergic and nonallergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated comorbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and nonallergic rhinitis, addressing the individual triggers of the disease as well as the patient-specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management, and treatment of nonallergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways, and digital health.",

keywords = "Allergen immunotherapy, Allergic rhinitis, Care pathway, Digital health, Immunotherapy, Mobile Airways Sentinel NetworK, Nonallergic rhinitis",

author = "Punita Ponda and Tara Carr and Rank, {Matthew A.} and Jean Bousquet",

note = "Publisher Copyright: {\textcopyright} 2022 American Academy of Allergy, Asthma & Immunology",

year = "2023",

month = jan,

doi = "10.1016/j.jaip.2022.09.010",

language = "English (US)",

volume = "11",

pages = "35--42",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy

T2 - Advances in the Last Decade

AU - Ponda, Punita

AU - Carr, Tara

AU - Rank, Matthew A.

AU - Bousquet, Jean

PY - 2023/1

Y1 - 2023/1

N2 - Chronic rhinitis encompassing both allergic and nonallergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated comorbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and nonallergic rhinitis, addressing the individual triggers of the disease as well as the patient-specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management, and treatment of nonallergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways, and digital health.

AB - Chronic rhinitis encompassing both allergic and nonallergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated comorbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and nonallergic rhinitis, addressing the individual triggers of the disease as well as the patient-specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management, and treatment of nonallergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways, and digital health.

KW - Allergen immunotherapy

KW - Allergic rhinitis

KW - Care pathway

KW - Digital health

KW - Immunotherapy

KW - Mobile Airways Sentinel NetworK

KW - Nonallergic rhinitis

UR - http://www.scopus.com/inward/record.url?scp=85139738378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139738378&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2022.09.010

DO - 10.1016/j.jaip.2022.09.010

M3 - Article

C2 - 36152989

AN - SCOPUS:85139738378

SN - 2213-2198

VL - 11

SP - 35

EP - 42

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 1

ER -

Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this